The multifunctional characteristics of SDOs, demonstrating both ACE and DPP-IV inhibitory activities [20], offer a distinctive opportunity for the development of dual-action preventive and therapeutic agents, potentially improving homeostasis and leading to effective approaches to treatment for patients with concurrent hypertension and diabetes. The gene discussed is ACE; the disease is hypertensive disorder.